We are live on ! Find out more
CRDF icon

Cardiff Oncology
CRDF

116 hedge funds and large institutions have $39.7M invested in Cardiff Oncology in 2026 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 30 increasing their positions, 37 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

908% more call options, than puts

Call options by funds: $1.19M | Put options by funds: $118K

69% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 13

5% more funds holding

Funds holding: 110 → 116 (+6)

4.49% less ownership

Funds ownership: 40.45% → 35.96% (-4.5%)

19% less repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 37

48% less capital invested

Capital invested by funds: $76.6M → $39.7M (-$36.8M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
116
Holders Change
+6
Holders Change %
+5.45%
% of All Funds
1.43%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
22
Increased
30
Reduced
37
Closed
13
Calls
$1.19M
Puts
$118K
Net Calls
+$1.07M
Net Calls Change
-$724K

Top Buyers

1
UBS Group
UBS Group
Switzerland
+$643K
2
Renaissance Technologies
Renaissance Technologies
New York
+$208K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$157K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$145K
5
AQR Capital Management
AQR Capital Management
Connecticut
+$136K

Top Sellers

1
William Blair & Company
William Blair & Company
Illinois
-$2.11M
2
Two Sigma Investments
Two Sigma Investments
New York
-$1.06M
3
CS
Candriam SCA
Luxembourg
-$968K
4
Goldman Sachs
Goldman Sachs
New York
-$512K
5
ACA
Acorn Capital Advisors
New York
-$411K
Name Holding Trade Value Shares
Change 		Change in
Stake
PNC Financial Services Group
101
PNC Financial Services Group
Pennsylvania
$1.15K +$1.33K +649 +1,119%
CA
102
Clearstead Advisors
Ohio
$1.13K – – –
EWA
103
EverSource Wealth Advisors
Alabama
$576 +$729 +355 New
AAP
104
Arax Advisory Partners
Colorado
$551 +$74 +36 +12%
SS
105
SBI Securities
Japan
$233 – – –
Nisa Investment Advisors
106
Nisa Investment Advisors
Missouri
$203 +$257 +125 New
RFP
107
Root Financial Partners
California
$154 +$195 +95 New
NA
108
NewEdge Advisors
Louisiana
$131 – – –
Northwestern Mutual Wealth Management
109
Northwestern Mutual Wealth Management
Wisconsin
$78 -$8 -4 -8%
Jones Financial Companies
110
Jones Financial Companies
Missouri
$78 – – –
AF
111
Allworth Financial
California
$33 +$41 +20 New
SS
112
Sunbelt Securities
Texas
$28 +$35 +17 New
RIL
113
Rothschild Investment LLC
Illinois
$18 +$23 +11 New
IA
114
IFP Advisors
Florida
$8 +$10 +5 New
FFA
115
Farther Finance Advisors
California
$2 -$659 -321 -100%
RJA
116
Ross\Johnson & Associates
Minnesota
$2 – – –
Two Sigma Advisers
117
Two Sigma Advisers
New York
– -$1.01M -360,500 Closed
CS
118
Candriam SCA
Luxembourg
– -$968K -344,437 Closed
HWM
119
HB Wealth Management
Georgia
– -$201K -71,491 Closed
HF
120
HRT Financial
New York
– -$82K -29,408 Closed
BIG
121
Brooklyn Investment Group
New York
– -$37.3K -12,649 Closed
BAM
122
Belpointe Asset Management
Nevada
– -$33.1K -11,778 Closed
ProShare Advisors
123
ProShare Advisors
Maryland
– -$31.8K -11,328 Closed
MIM
124
MetLife Investment Management
New Jersey
– -$17.5K -6,230 Closed
AB
125
Amalgamated Bank
New York
– -$5K -1,948 Closed
2 3 4
5
6

CRDF Hedge Fund Activity: Q1 2026 in Review

116 of the 8,125 institutional investors tracked by Wall St. Rank reported a position in Cardiff Oncology (CRDF) for Q1 2026, worth a combined $39.7M — down 48% from $76.6M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new CRDF positions and 13 closed out — a net gain of 9 holders — while 30 added to existing stakes and 37 trimmed.

The largest buyer was UBS Group, adding an estimated $643K. The largest seller was William Blair & Company, cutting an estimated $2.11M.

  • 116 institutional investors held Cardiff Oncology (CRDF) as of Q1 2026, up from 110 in Q4 2025.
  • Funds reported $39.7M of Cardiff Oncology stock for Q1 2026, down 48% quarter-over-quarter.
  • 22 funds opened new Cardiff Oncology positions in Q1 2026 and 13 closed out, a net change of +9 holders.
  • The largest Cardiff Oncology buyer in Q1 2026 was UBS Group, an estimated $643K added.
  • The largest Cardiff Oncology seller in Q1 2026 was William Blair & Company, an estimated $2.11M sold.

Based on aggregated 13F filings for Q1 2026.